Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Oxford Biodyn (OBD) Regulatory News

Date Source Headline
23rd Oct 2023 11:09 am RNS PDMR Dealing / Grant of Share Options
20th Oct 2023 9:45 am RNS Director/PDMR Shareholding
18th Oct 2023 7:00 am RNS Bupa UK to cover EpiSwitch® CiRT for customers
6th Oct 2023 5:44 pm RNS Director/PDMR Shareholding
3rd Oct 2023 4:37 pm RNS Holding(s) in Company
3rd Oct 2023 7:00 am RNS OBD receives reimbursement code for PSE test
26th Sep 2023 7:00 am RNS OBD launches 94% accurate PSE test in US and UK
7th Sep 2023 10:18 am RNS Holding(s) in Company
1st Sep 2023 12:34 pm RNS Amendment: Director/PDMR Shareholding
31st Aug 2023 4:02 pm RNS Holding(s) in Company
25th Aug 2023 9:00 am RNS Holding(s) in Company
22nd Aug 2023 3:58 pm RNS Holding(s) in Company
22nd Aug 2023 7:00 am RNS Holding(s) in Company
22nd Aug 2023 7:00 am RNS Holding(s) in Company
18th Aug 2023 11:44 am RNS Result of General Meeting
8th Aug 2023 4:00 pm RNS Holding(s) in Company
4th Aug 2023 7:00 am RNS Results of PrimaryBid Offer
2nd Aug 2023 7:00 am RNS Result of Placing and Subscription
1st Aug 2023 4:55 pm RNS PrimaryBid Offer
1st Aug 2023 4:54 pm RNS Proposed Fundraising
30th May 2023 7:00 am RNS Half-year Report
16th May 2023 7:00 am RNS Notice of Interim Results and Investor Webinar
15th May 2023 7:00 am RNS CiRT expanded validation for ICI immunotherapies
2nd May 2023 7:00 am RNS US PACT Award for prognosis test for IOrelated HPD
18th Apr 2023 7:00 am RNS Director/PDMR Shareholding
5th Apr 2023 7:00 am RNS Business update for PSE and CiRT tests
30th Mar 2023 1:04 pm RNS Result of AGM
23rd Mar 2023 3:19 pm RNS Holding(s) in Company
22nd Mar 2023 2:22 pm RNS Holding(s) in Company
15th Mar 2023 11:43 am RNS AIM Rule 17 Schedule 2(g) Update
3rd Mar 2023 4:33 pm RNS Publication of FY22 Annual Report
23rd Feb 2023 10:36 am RNS PDMR Dealing
6th Feb 2023 7:00 am RNS OBD Prostate Screening EpiSwitch Blood Test Update
27th Jan 2023 2:36 pm RNS Director/PDMR Shareholding
24th Jan 2023 7:00 am RNS Preliminary Results and Notice of AGM
21st Dec 2022 7:00 am RNS Notice of FY22 Results and Investor Webinar
19th Dec 2022 7:00 am RNS OBD in San Francisco for JPM Healthcare conf 2023
16th Dec 2022 7:00 am RNS Initial assessment of EpiSwitch assay in ALS trial
14th Dec 2022 12:35 pm RNS Holding(s) in Company
14th Dec 2022 7:00 am RNS Exercise period extension - existing share options
FTSE 100 Latest
Value8,992.12
Change19.48